Research Alliance Corp. II announced the pricing of its $130 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “RACB,” Thursday, March 18.
The new company aims to combine with a healthcare target that would be funded at least one year past a key value inflection point through the deal. Research Alliance II is led by CEO and Chairman Peter Kolchinsky, CFO Tess Cameron and CIO Matthew Hammond.
Total SPAC deal count for 2021 year-to-date is now 269. This offering is expected to close on Monday, March 22.
Jefferies LLC is serving as the sole book-running manager for this offering. Goodwin Procter LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.